Corcept Therapeutics
CORT
CORT
156 hedge funds and large institutions have $824M invested in Corcept Therapeutics in 2017 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 68 increasing their positions, 38 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
24% more capital invested
Capital invested by funds: $664M → $824M (+$160M)
16% more funds holding
Funds holding: 135 → 156 (+21)
8% more ownership
Funds ownership: 53.69% → 61.7% (+8%)
Holders
156
Holding in Top 10
5
Calls
$2.4M
Puts
$673K
Top Buyers
| 1 | +$13.9M | |
| 2 | +$12.6M | |
| 3 | +$9.73M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.14M |
| 5 |
CCM
Consonance Capital Management
New York
|
+$7.49M |
Top Sellers
| 1 | -$6.26M | |
| 2 | -$6.09M | |
| 3 | -$4.9M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$4.39M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.06M |